期刊文献+

风湿病相关的骨质疏松症值得关注 被引量:3

原文传递
导出
摘要 骨质疏松症(osteoporosis,OP)是一种以骨强度下降、骨折风险增加为特征的骨骼系统疾病,早在1993年《美国风湿病学会对关节炎和风湿性疾病的命名和分类》已将OP包括其中,但由于我国风湿病专业起步较晚,风湿病学者对其认识和研究存在诸多不足,发表有关OP的研究文章的数量少于内分泌和骨科等专业,风湿免疫科临床医生对OP诊治也缺乏足够的重视,漏诊漏治的情况并不鲜见.本文就风湿病相关骨质疏松症的流行病学现状、发病机制和存在的一些临床问题加以探讨,希望风湿病专业医生能关注OP这一重要课题,积极开展相关的基础和临床研究,并在临床实践中及早发现、及早干预和防治,以改善患者预后.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2015年第11期721-723,共3页 Chinese Journal of Rheumatology
  • 相关文献

参考文献14

  • 1Van Staa TP, Geusens P, Bijlsma JW, et al. Clinical assessmentof the long-term risk of fracture in patients with rheumatoidarthritis[J]. Arthritis Rheum, 2006, 54(10): 3104-3112.
  • 2Klingberg E, Lorentzon M, Mellstrom D, et al. Vertebralfractures in ankylosing spondylitis are associated with lowerbone mineral density in both central and peripheral skeleton[J].J Rheumatol, 2012,39(10): 1987-1995.
  • 3Kalla AA, Fataar AB, Jessop SJ, et al. Loss of trabecularbone mineral density in systemic lupus erythematosusfj]. ArthritisRheum, 1993, 36(12): 1726-1734.
  • 4Mok CC, Mak A, Ma KM. Bone mineral density in post-menopausal Chinese patients with systemic lupus erythematosus[J]. Lupus, 2005,14(2): 106-112.
  • 5Boyanov M,Robeva R,Popivanov P. Bone mineral densitychanges in women with systemic lupus[J]. Erythematosus, 2003..
  • 6Uaratanaworig S,Deesomchoke U, Lertmaharit S,et al. Bonemineral density in premenopausal women with systemic lupuserythematosus[J]. J Rheumatol, 2003, 30(11): 2365-2368.
  • 7Bultink IE. Osteoporosis and fractures in systemic lupus erythe-matosusfj]. Arthritis Care Res (Hoboken), 2012,64( 1): 2-8.
  • 8Maruotti N, Corrado A, Cantatore FP. Osteoporosis and rheum-atic diseases[J]. Reumatismo, 2014,66(2) : 125-135.
  • 9Geusens P,Lems WF. Osteoimmunology and osteoporosis [J].Arthritis Res Ther, 2011, 13(5): 242.
  • 10Bultink IE, Vis M,van der Horst-Bruinsma IE,et al. In-flammatory rheumatic disorders and bone[J]. Curr RheumatolRep, 2012,14(3): 224-230.

二级参考文献29

  • 1中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南.中国骨质疏松和骨矿物盐疾病杂志,2011,4: 2-17.
  • 2NIH Consensus Development Panel on Osteoporosis Prevention,Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, andtherapy. JAMA, 2001,285: 785-795.
  • 3Compston JE. Management of glucocorticoid-induced osteoporosis,Nat Rev Rheumatol, 2010,6: 82-88.
  • 4Lane NE, Lukert B. The science and therapy of glucocorticoid-induced bone loss. Osteoporos, 1998, 27: 465-483.
  • 5Grossman JM, Gordon R, Ranganath VK, et al. American col-lege of rheumatology 2010 recommendations for the preventionand treatment of glucocorticoid-induced osteoporosis. Arthritis CareRes, 2010, 62: 1515-1526.
  • 6Wong CA, Walsh U, Smith CJ, et al. Inhaled corticosteroid useand bone-mineral density in patients with asthma. Lancet, 2000,355: 1399-1403.
  • 7Ziegler R, Kasperk C. Glucocorticoid-induced osteoporosis: pre-vention and treatment. Steroids, 1998,63: 344-348.
  • 8Ziegler R, Kasperk C. Glucocorticoid-induced osteoporosis: pre-vention and treatment. Steroids, 1998,63: 344-348.
  • 9Van Staa TP, Leufkens HGM, Abenhaim L, et al. Use of corti-costeroids and risk of fractures. J Bone Miner Res, 2000, 15:993-1000.
  • 10Adinoff AD, Hollister JR. Steroid-induced fractures and boneloss in patients with asthma. N Engl J Med. 1983,309: 265-268.

共引文献65

同被引文献48

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部